Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Taiki Tojo

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
International Heart Journal|September 16, 2015
Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-κB PathwayTakehiro Hashikata, Minako Yamaoka-Tojo, Sayaka Namba, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2008
Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patientsRyozo Nagai, Tohru Izumi, Masahiko Kurabayashi, et al.
Nutrients|July 27, 2022
Advanced Glycation End Products Are Associated with Diabetes Status and Physical Functions in Patients with Cardiovascular DiseaseTomoya Hirai, Kazuhiro Fujiyoshi, Satoru Yamada, et al.
BBA Clinical|December 18, 2015
Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosisSayaka Namba, Minako Yamaoka-Tojo, Takehiro Hashikata, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2015
Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)Lisa Kitasato, Takao Shimohama, Yuki Ikeda, et al.
Internal Medicine (Tokyo, Japan)|November 20, 2010
Hemodialysis is an independent predictor of coronary in-stent restenosis after paclitaxel eluting stent implantationIchiro Takeuchi, Masahiko Moriguchi, Ryuta Imaki, et al.
International Heart Journal|September 6, 2019
Contrast Volume and Decline in Kidney Function in Optical Coherence Tomography-Guided Percutaneous Coronary InterventionTeruyoshi Nemoto, Yoshiyasu Minami, Toshimitsu Sato, et al.
International Heart Journal|April 12, 2019
Impaired Flow-Mediated Dilation and Severity and Vulnerability of Culprit Plaque in Patients with Coronary Artery DiseaseTeruyoshi Nemoto, Yoshiyasu Minami, Minako Yamaoka-Tojo, et al.
International Heart Journal|August 31, 2018
Endothelial Dysfunction Is Associated with Cognitive Impairment of Elderly Cardiovascular Disease PatientsKazuhiro Fujiyoshi, Minako Yamaoka-Tojo, Yoshiyasu Minami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 13, 2012
Phosphoglucomutase activity as a novel biomarker in patients with acute myocardial infarctionMakoto Nishinari, Naoyoshi Aoyama, Zensuke Ogawa, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
International Heart Journal|September 16, 2015
Rivaroxaban Inhibits Angiotensin II-Induced Activation in Cultured Mouse Cardiac Fibroblasts Through the Modulation of NF-κB PathwayTakehiro Hashikata, Minako Yamaoka-Tojo, Sayaka Namba, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|March 26, 2008
Rationale and design of a study to examine lower targets for low-density lipoprotein-cholesterol and blood pressure in coronary artery disease patientsRyozo Nagai, Tohru Izumi, Masahiko Kurabayashi, et al.
Nutrients|July 27, 2022
Advanced Glycation End Products Are Associated with Diabetes Status and Physical Functions in Patients with Cardiovascular DiseaseTomoya Hirai, Kazuhiro Fujiyoshi, Satoru Yamada, et al.
BBA Clinical|December 18, 2015
Long-term warfarin therapy and biomarkers for osteoporosis and atherosclerosisSayaka Namba, Minako Yamaoka-Tojo, Takehiro Hashikata, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|June 10, 2015
Clinical outcomes of chronic kidney disease patients treated with everolimus-eluting stents (EES) and paclitaxel-eluting stents (PES)Lisa Kitasato, Takao Shimohama, Yuki Ikeda, et al.
Internal Medicine (Tokyo, Japan)|November 20, 2010
Hemodialysis is an independent predictor of coronary in-stent restenosis after paclitaxel eluting stent implantationIchiro Takeuchi, Masahiko Moriguchi, Ryuta Imaki, et al.
International Heart Journal|September 6, 2019
Contrast Volume and Decline in Kidney Function in Optical Coherence Tomography-Guided Percutaneous Coronary InterventionTeruyoshi Nemoto, Yoshiyasu Minami, Toshimitsu Sato, et al.
International Heart Journal|April 12, 2019
Impaired Flow-Mediated Dilation and Severity and Vulnerability of Culprit Plaque in Patients with Coronary Artery DiseaseTeruyoshi Nemoto, Yoshiyasu Minami, Minako Yamaoka-Tojo, et al.
International Heart Journal|August 31, 2018
Endothelial Dysfunction Is Associated with Cognitive Impairment of Elderly Cardiovascular Disease PatientsKazuhiro Fujiyoshi, Minako Yamaoka-Tojo, Yoshiyasu Minami, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 13, 2012
Phosphoglucomutase activity as a novel biomarker in patients with acute myocardial infarctionMakoto Nishinari, Naoyoshi Aoyama, Zensuke Ogawa, et al.
Pageof 7